A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022
Clinical trial NCT01254656 · TERMINATED
Trial details
- NCT number
- NCT01254656
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2013-04-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.